CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Shire Orphan Therapies LLC v. Fresenius Kabi USA, LLC

1:15-cv-01102

Overview

Case Number 1:15-cv-01102
Filing Date 2015-11-30
Status Terminated
Termination Date 2018-06-05
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Sandoz Inc. Operating Company

Represented By

2 Attorneys Listed

Julia M. Johnson

Email: jmjohnson@winston.com

Dominick T. Gattuso

Heyman Enerio Gattuso & Hirzel LLP

Tel: +1 (302) 472-7311
Fax: +1 (302) 472-7301

300 Delaware Avenue, Suite 200, Wilmington, DE 19801

Fresenius Kabi USA, LLC Operating Company

Represented By

10 Attorneys Listed

Jeff Castellano

DLA Piper LLP

Tel: +1 (302) 468-5671

1201 N. Market St., Suite 2100

David M. Fry

JPMorgan Chase & Co.

Tel: +1 (302) 455-3374

JPMorgan Chase & Co., 4041 Ogletown Stanton Road

William G. James

Email: william.james@allenovery.com

Samuel Sherry

Email: ssherry@goodwinlaw.com

Kathleen A. McGuinness

Email: kmcguinness@goodwinlaw.com

John Coy Stull

UNDELIVERABLE EMAIL 8/20/2019

John W. Shaw

Shaw Keller LLP

Tel: +1 (302) 298-0701

I.M. Pei Building, 1105 North Market Street

Daryl L. Wiesen

Email: dwiesen@goodwinlaw.com

Charles T. Cox , Jr.

Email: Charlie.Cox@wilmerhale.com

Karen Elizabeth Keller

Shaw Keller LLP

Tel: +1 (302) 298-0700

1105 North Market Street, 12th Floor, Wilmington, DE 19801

Plaintiff

Shire Orphan Therapies LLC Operating Company

Represented By

9 Attorneys Listed

Ying-Zi Yang

Email: yyang@mayerbrown.com

Sandra Kuzmich

Email: skuzmich@haugpartners.com

Laura A. Fanelli

UNDELIVERABLE EMAIL 7/7/17

Laura A. Chubb

Email: lchubb@haugpartners.com

Elizabeth J. Murphy

Email: EMurphy@haugpartners.com

Edgar H. Haug

Email: ehaug@haugpartners.com

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Daniel G. Worley , Jr.

Email: dworley@haugpartners.com

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Sanofi-Aventis Deutschland GmbH NPE (Individual / Inventor)

Represented By

2 Attorneys Listed

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 17 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (17): 🇩🇪 Germany 🇺🇸 US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US5648333
Peptides having bradykinin antagonist action
Filed: 1995-06-07
Issued: 1997-07-15
Expired (Term Ended) +1499d PTA
Expires: 2019-07-15

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+1499 days) / In re Cellect scrutiny applies.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

2

Dispositive

0

Granted

0

Denied

0

Pending / Review

2

Motions by Category

Procedural / Extension Motion 2

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for the parties to submit a Status Report and Proposed Scheduling Order to February 24, 2016 - filed by Sanofi-Aventis Deutschland Gm...
Entry #15 • 2016-02-11 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to Respond to the Complaint to January 13, 2016 - filed by Fresenius Kabi USA, LLC. (Keller, Karen) (Entered: 12/22/2015)
Entry #7 • 2015-12-22 Document →

Docket Entries

(22 total)
Pleading / Complaint

COMPLAINT filed against Fresenius Kabi USA, LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1835173.) - filed by Shire Orphan Therapies LLC, Sanofi-Aventis Deutschland GmbH. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(klc) (Entered: 11/30/2015)

Entry #1 • 2015-11-30
1
Pleading / Complaint

COMPLAINT filed against Fresenius Kabi USA, LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1835173.) - filed by Shire Orphan Therapies LLC, Sanofi-Aventis Deutschland GmbH. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(klc) (Entered: 11/30/2015)

Entry #1 • 2015-11-30
2
Pleading / Complaint

COMPLAINT filed against Fresenius Kabi USA, LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1835173.) - filed by Shire Orphan Therapies LLC, Sanofi-Aventis Deutschland GmbH. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(klc) (Entered: 11/30/2015)

Entry #1 • 2015-11-30
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (klc) (Entered: 11/30/2015)

Entry #2 • 2015-11-30
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: SEE ANDA FORM. Date of Expiration of Patent: 7/15/2019.Thirty Month Stay Deadline: 2/25/2019. (klc) (Entered: 11/30/2015)

Entry #3 • 2015-11-30
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc